๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
719 KB
Volume
39
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Predictors of time to requiring dopamine
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
โœ Connie Marras; Michael P. McDermott; Ken Marek; Paula Rochon; Gary Naglie; Carol ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB ๐Ÿ‘ 1 views

## Abstract The rate of progression of Parkinson's disease (PD) is highly variable. Knowledge of factors associated with disease milestones and commonly used research outcome measures helps with patient counseling and guides the design and interpretation of clinical studies. The objective of the st

The impact of treatment of depression on
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease
โœ Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Margery H. Mark; Michae ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 318 KB ๐Ÿ‘ 1 views

## Abstract Parkinson's disease (PD) is a common neurodegenerative disease affecting up to one million individuals in the United States. Depression is found in 40 to 50% of these patients and is associated with a variety of poor outcomes for both patients and their families. Despite this, there are